BioPharma in 2024: At a Crossroads
FTI Consulting’s Healthcare & Life Sciences Industry Outlook 2024 shares results from a survey of decision-makers in communications, investor relations, public affairs, among other business-critical areas, and finds the industry at an inflection point, facing risks as well as areas of opportunity. Learn more about how organizations can position for success in 2024 in the report.